ADC Therapeutics (ADCT) Long-Term Deferred Tax (2021 - 2023)
ADC Therapeutics (ADCT) posted Long-Term Deferred Tax of $35.4 million for Q3 2023, up 1.66% sequentially from $34.8 million in Q2 2023, and up 5.36% YoY from $33.6 million in Q3 2022.
ADC Therapeutics (ADCT) Long-Term Deferred Tax (2021 - 2023) Analysis & Trends
ADC Therapeutics has reported Long-Term Deferred Tax for 3 years, with the latest figure at $35.4 million in Q3 2023.
- Quarterly Long-Term Deferred Tax rose 5.36% year-over-year to $35.4 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $35.4 million (up 5.36% YoY) and the FY2022 annual result came in at $37.1 million, up 42.44% from the prior year.
- Long-Term Deferred Tax rose to $35.4 million in Q3 2023 per ADCT's latest filing, from $34.8 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $37.1 million in Q4 2022 and troughed at $26.0 million in Q4 2021.
- A 3-year average of $32.3 million and a median of $33.8 million in 2022 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2022 and 2023: Long-Term Deferred Tax surged 42.44% in 2022, then fell 7.69% in 2023.
- Over 3 years, Long-Term Deferred Tax stood at $26.0 million in 2021, then surged by 42.44% to $37.1 million in 2022, then slipped by 4.59% to $35.4 million in 2023.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $35.4 million, $34.8 million, and $27.6 million for Q3 2023, Q2 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | ADC Therapeutics | 154.55 Mn | -64.56 Mn | 17.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 35.40 Mn |
| Jun 30, 2023 | 34.82 Mn |
| Mar 31, 2023 | 27.61 Mn |
| Dec 31, 2022 | 37.10 Mn |
| Sep 30, 2022 | 33.60 Mn |
| Jun 30, 2022 | 34.04 Mn |
| Mar 31, 2022 | 29.91 Mn |
| Dec 31, 2021 | 26.05 Mn |